Can fluvoxamine (Luvox) be combined with bupropion (Wellbutrin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Luvox and Wellbutrin Be Combined?

Yes, fluvoxamine (Luvox) can be combined with bupropion (Wellbutrin), and this combination is used in clinical practice for treatment-resistant depression or to augment antidepressant response, though important drug interaction monitoring is required.

Key Drug Interaction Concern

The primary concern with this combination is that fluvoxamine is a potent inhibitor of CYP2B6 and other metabolic pathways that process bupropion 1. The FDA label for Wellbutrin specifically identifies that "in vitro studies suggest that paroxetine, sertraline, norfluoxetine, fluvoxamine, and nelfinavir inhibit the hydroxylation of bupropion" 1. This means:

  • Fluvoxamine will increase bupropion blood levels by inhibiting its metabolism
  • Hydroxybupropion (the active metabolite) levels will decrease while parent bupropion accumulates
  • This increases seizure risk, which is bupropion's most serious dose-dependent adverse effect

Clinical Evidence Supporting the Combination

Despite the metabolic interaction, clinical data supports this combination's use:

  • Preclinical studies demonstrate synergistic antidepressant effects: Animal models show that combining bupropion with fluvoxamine at subtherapeutic doses produces antidepressant effects superior to either agent alone 2

  • Open-label clinical experience is positive: A retrospective study of 27 patients combining serotonin reuptake inhibitors (including fluvoxamine) with bupropion showed 70% had greater symptomatic improvement than with monotherapy, with no seizures reported 3

  • Systematic review supports combination therapy: Evidence indicates that combining bupropion with SSRIs (including fluvoxamine) is "generally well tolerated, can boost antidepressant response, and can reduce SSRI-associated sexual side effects" 4

Safe Prescribing Algorithm

When combining these medications:

  1. Start with conservative bupropion dosing - Use lower doses than typical monotherapy (the clinical series used mean bupropion 243 mg/day) 3

  2. Monitor closely for seizure risk factors:

    • Avoid in patients with seizure history, eating disorders, or abrupt alcohol/benzodiazepine discontinuation 1
    • Watch for dose-dependent adverse effects suggesting accumulation
  3. Assess within 1-2 weeks of initiation for:

    • Neuropsychiatric symptoms (agitation, irritability, unusual behavior changes)
    • Signs of excessive bupropion effect (tremor, insomnia, anxiety)
    • Suicidal ideation (FDA black box warning for all antidepressants) 5, 1
  4. Specific monitoring for this combination:

    • Tremor (reported in 11% of combination therapy) 3
    • Insomnia (22% incidence) 3
    • Sexual dysfunction (41%, though typically lower than SSRI monotherapy) 3

Clinical Context from Guidelines

The American College of Physicians guidelines establish that no single second-generation antidepressant is superior to another in efficacy 6, 5. However, they note that "bupropion is associated with a lower rate of sexual adverse events than fluoxetine or sertraline, whereas paroxetine has higher rates of sexual dysfunction than fluoxetine, fluvoxamine, nefazodone, or sertraline" 5. This provides rationale for adding bupropion to fluvoxamine specifically to counteract sexual side effects.

Important Caveats

  • Do not use maximum doses of both agents simultaneously - The metabolic inhibition means standard bupropion dosing may produce supra-therapeutic levels
  • Fluvoxamine has additional interaction concerns - It inhibits CYP1A2 and CYP3A4, affecting metabolism of many other medications 7
  • One case report documents oscillopsia (visual disturbance) in a patient on this combination, which resolved with fluvoxamine discontinuation 8
  • Long-term data suggests fluvoxamine may be less effective than other SSRIs for preventing recurrence 9, though this doesn't preclude combination use

Bottom Line

This combination is clinically viable and supported by evidence, but requires dose adjustment (lower bupropion doses), close monitoring for seizure risk factors, and awareness of the metabolic interaction. The combination may be particularly useful when fluvoxamine alone causes sexual dysfunction or when either agent alone provides inadequate response.

Related Questions

Is it appropriate to start Buspirone (Buspar) together with bupropion (Wellbutrin) in a patient who requires both anxiolytic and antidepressant therapy, and what dosing and monitoring should be used?
Is it safe to combine fluoxetine (Prozac), buspirone (Buspar), and bupropion (Wellbutrin)?
Is it safe to combine bupropion with fluoxetine, and what dosing adjustments or monitoring are required to avoid seizures and serotonin syndrome?
What are the risks, dosing limits, and monitoring recommendations for co‑administration of bupropion (Wellbutrin) and escitalopram (Lexapro)?
Can fluoxetine (Prozac) and bupropion (Wellbutrin) be used together in adult patients?
Can Myonal (orphenadrine) be combined with Celebrex (celecoxib) safely?
Can oral contrast be administered in a patient with suspected intestinal obstruction?
What is the role of vitamin D (cholecalciferol) in measles management, and what are the recommended supplementation doses and target serum 25‑hydroxyvitamin D levels?
In patients with Kawasaki disease who develop coronary artery stenosis or ischemia, what are the indications for revascularisation and the preferred surgical (coronary artery bypass grafting) versus percutaneous (PCI) approaches based on age, aneurysm size, and lesion characteristics?
In a healthy adult without renal disease, what urine volume, urine specific gravity, and urine flow rate would be expected over a 2.5‑hour period after ingesting water, isotonic fluid, hypertonic salt tablets, and coffee?
Should mannitol be used in a patient with bilateral cerebellar infarction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.